To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models

利用谱系追踪模型研究 EMT 在肿瘤转移和化疗耐药中的贡献

• 批准号: 10651750
• 负责人: Dingcheng Gao
• 金额: $ 47.92万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-17 至 2025-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10651750
• 关键词: Apoptosis; BT 474; Bar Codes; Blood; Breast Cancer Cell; Breast Cancer Model; Breast cancer metastasis; CCL7 gene; CRISPR/Cas technology; Cell Line; Cells; Chemoresistance; Circulation; Clustered Regularly Interspaced Short Palindromic Repeats; Communities; Development; Disease; E-Cadherin; Embryonic Development; Epithelium; Event; Exhibits; Fluorescence; Genes; Genetic; Homing; Human; Individual; Invaded; Knock-in; Lung; MDA MB 231; Mediating; Mesenchymal; Mesenchymal Cell Neoplasm; Metastatic Neoplasm to the Lung; Modeling; Mouse Mammary Tumor Virus; Mus; Nature; Neoplasm Metastasis; Phenotype; Primary Neoplasm; Process; Property; Recurrence; Reporter; Reporting; Resistance; Role; Site; Snails; Transgenic Mice; Vimentin; chemotherapy; epithelial to mesenchymal transition; improved; in vivo; migration; neoplastic cell; novel; polyoma middle tumor antigen; programs; stemness; transcription factor; transdifferentiation; tumor; tumor progression

Epithelial to mesenchymal transition (EMT) has been enthusiastically proposed as an essential mechanism for tumor metastasis, since the EMT-associated features such as migration, invasion, resistance to apoptosis and stemness properties, adequately meet the requirements for metastasis. Taken the challenges of tracing the EMT process in vivo, we developed a strategy of using a mesenchymal-specific Cre-mediated switch of fluorescent markers in a multiple-transgenic mouse (MMTV-PyMT:Fsp1-Cre:Rosa26mT/mG, Tri-PyMT). Surprisingly, we found that lung metastases were predominantly composed of pre-EMT RFP+ tumor cells exhibiting epithelial phenotypes under normal conditions. Importantly, the post-EMT tumor cells did exhibit resistance to chemotherapy, significantly contributed to recurrent lung metastases after chemotherapy. These findings pointed to the complexity of EMT contributions in tumor progression and revived vigorous discussions in the community. Given the transient, reversible and dynamic natures of the EMT process, and concerns about the Tri-PyMT model, we proposed new lineage tracing models to study the roles of EMT in metastasis and chemoresistance. Aim 1. To explore the contributions of EMT mechanism in tumor metastasis and chemoresistance by using Snail-CreERT2 mediated EMT lineage tracing model. The Fsp1-Cre mediated Tri-PyMT model may not be sufficient to report all EMT events. Metastatic cells could undergo EMT by activating distinct EMT transcription factors (TFs) such as Snail. Therefore, we have established a Snail-CreERT2–mediated EMT lineage tracing model. In-depth analyses will be performed to clarify the roles of EMT in metastasis and chemoresistance with this model. Aim 2. To explore the dynamic changes of EMT statuses in human breast cancer metastasis and chemoresistance. EMT reporter cell lines (MDA-MB-231:Vim/RFP and BT-474:ECAD/GFP cells) carry knockin fluorescent tags within EMT marker genes (Vimentin and E-cadherin, respectively). Unlike the Cre-mediated models, the fluorescence expression in these cells is quantitative and reversible, which allows us to analyze the dynamic changes of EMT status with and without chemotherapy in human breast cancer models. Aim 3. To assess the evolutionary lineages of metastasis-initiating cells and the involvement of EMT mechanism via genetic barcoding models. In addition to using EMT markers, we will genetically barcode the Tri-PyMT cells using the homing-CRISPR technique. This model will allow us to depict the evolutionary trajectories from primary tumor cells to individual metastases, and determine the origins of the metastasis (pre- EMT vs. post-EMT cells). Further, we will develop genetic barcoding mice (MARC:CRISPR:PyMT) for lineage tracing of spontaneous metastatic cells and assessing the contributions of the EMT program to metastasis. Impact: Resolving the controversies in the field will not only improve our mechanistic understanding of tumor metastasis but also provide novel targets/opportunities in combatting the deadly disease.

上皮到间充质转变（EMT）已被热情地提出作为一种基本机制 肿瘤转移，因为EMT相关的特征，例如迁移，侵袭，对凋亡的抵抗力和 干性特性充分满足转移的要求。采取追踪EMT的挑战 在体内过程中，我们制定了一种使用间充质特异性CRE介导的荧光转换的策略 多转基因小鼠（MMTV-PYMT：FSP1-CRE：ROSA26MT/MG，TRI-PYMT）中的标记。令人惊讶的是，我们 发现肺转移主要由EMT RFP+肿瘤细胞组成 正常条件下的表型。重要的是，EMT后肿瘤细胞确实存在于 化学疗法显着导致化疗后复发性肺转移。这些发现指出 EMT在肿瘤发展中的贡献的复杂性，并在社区中恢复了激烈的讨论。 鉴于EMT过程的瞬时，可逆和动态的本质，并担心Tri-Pymt 模型，我们提出了新的谱系追踪模型，以研究EMT在转移和化学上的作用。 目标1。探索EMT机制在肿瘤转移和化学上的贡献 使用Snail-Creert2介导的EMT谱系跟踪模型。 FSP1-CRE介导的Tri-PYMT模型可能不会 足以报告所有EMT事件。转移细胞可以通过激活不同的EMT转录来进行EMT 因素（TF），例如蜗牛。因此，我们已经建立了一个蜗牛 - 雷特2介导的EMT谱系跟踪 模型。将进行深入分析，以阐明EMT在转移和化学上的作用 这个模型。 目标2。探索人类乳腺癌转移和 化学抗性。 EMT报告基细胞系（MDA-MB-231：VIM/RFP和BT-474：ECAD/GFP细胞）携带敲击 EMT标记基因（波形蛋白和E-钙粘蛋白）中的荧光标签。与CRE介导的不同 模型，这些细胞中的荧光表达是定量和可逆的，这使我们能够分析 在人类乳腺癌模型中，EMT状态有和没有化学疗法的动态变化。 目的3。评估转移性细胞的进化谱系和EMT的参与 通过遗传条形码模型的机制。除了使用EMT标记外，我们还将基因条形码 使用HOHONG-CRISPR技术的三元细胞。该模型将使我们能够描述进化 从原发性肿瘤细胞到单个转移的轨迹，并确定转移的起源（前 EMT与EMT细胞）。此外，我们将开发遗传条形码小鼠（MARC：CRISPR：PYMT） 追踪赞助转移细胞并评估EMT程序对转移的贡献。 影响：解决现场的争议不仅会改善我们对肿瘤的机械理解 转移，但还提供了抗击致命疾病的新目标/机会。